化学
溶剂
组合化学
结晶
芳基
铃木反应
亲核芳香族取代
有机化学
亲核取代
烷基
作者
Fabienne Hoffmann-Emery,Katrin Niedermann,Pankaj D. Rege,Manuel Konrath,Christian Lautz,Anne Kraft,Carine Steiner,Fritz Bliss,André Hell,R. Fischer,Diane E. Carrera,Danial Beaudry,Rémy Angelaud,Sushant Malhotra,Francis Gosselin
标识
DOI:10.1021/acs.oprd.1c00389
摘要
A sustainable second-generation process for GDC-0134 was developed with a particular focus on safety and greenness, while complying with strong specifications to supply pivotal clinical studies. Through these efforts, we discovered solvents to replace the solvents classified as substances of very high concern by the REACH regulation in two SNAr steps. We further established a safer and faster way to oxidize the sulfanyl to the sulfonyl intermediate by dosing H2O2 at higher temperatures, reducing accumulation while minimizing uncontrolled H2O2 decomposition. The reaction conditions for the Suzuki coupling and the second SNAr were modified to increase the selectivity in these two steps. A change in the solvent for the final crystallization allowed operation at higher concentrations and delivery of a highly pure active pharmaceutical ingredient (API). The new improved process reduced the process mass intensity by approximately 40% and was successfully used to produce 150 kg of GDC-0134.
科研通智能强力驱动
Strongly Powered by AbleSci AI